CoChat
Sign Up
Cited by 48Global Cancer Incidence and ScreeningAdvances in Oncology and RadiotherapyGlobal Public Health Policies and Epidemiology

A socio-ecological framework for cancer prevention in low and middle-income countries

Open access
Akinyemiju, Tomi, Ogunsina, Kemi, Gupta, Anjali, Liu, Iris, Braithwaite, Dejana, Hiatt, Robert A.·2022·Frontiers in Public Health
DOI 10.3389/fpubh.2022.884678PMC PMC9204349
Open this paper in CoChat — free accountOpen PDF

Abstract

Cancer incidence and mortality rates continue to rise globally, a trend mostly driven by preventable cancers occurring in low-and middle-income countries (LMICs). There is growing concern that many LMICs are ill-equipped to cope with markedly increased burden of cancer due to lack of comprehensive cancer control programs that incorporate primary, secondary, and tertiary prevention strategies. Notably, few countries have allocated budgets to implement such programs. In this review, we utilize a socio-ecological framework to summarize primary (risk reduction), secondary (early detection), and tertiary (treatment and survivorship) strategies to reduce the cancer burden in these countries across the individual, organizational, community, and policy levels. We highlight strategies that center on promoting health behaviors and reducing cancer risk, including diet, tobacco, alcohol, and vaccine uptake, approaches to promote routine cancer screenings, and policies to support comprehensive cancer treatment. Consistent with goals promulgated by the United Nations General Assembly on Noncommunicable Disease Prevention and Control, our review supports the development and implementation of sustainable national comprehensive cancer control plans in partnership with local communities to enhance cultural relevance and adoption, incorporating strategies across the socio-ecological framework. Such a concerted commitment will be necessary to curtail the rising cancer and chronic disease burden in LMICs.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fpubh.2022.884678

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 92 · Cited by 48

Research works printed but not linked: 91

  1. [1]Sung H Ferlay J Siegel RL Laversanne M Soerjomataram I Jemal A. Global Cancer Statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. (2021) 71: 209– 49. 10.3322/caac.21660 33538338 · DOI · Paper page
  2. [2]Fitzmaurice C Abate D Abbasi N Abbastabar H Abd-Allah F Abdel-Rahman O. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. (2019) 5: 1749– 68. 10.1001/jamaoncol.2019.2996 31560378 PMC6777271 · DOI
  3. [4]Prager GW Braga S Bystricky B Qvortrup C Criscitiello C Esin E. Global cancer control: responding to the growing burden, rising costs and inequalities in access. ESMO Open. (2018) 3: e000285. 10.1136/esmoopen-2017-000285 29464109 PMC5812392 · DOI
  4. [5]Gopalappa C Guo J Meckoni P Munkhbat B Pretorius C Lauer J. A Two-step markov processes approach for parameterization of cancer state-transition models for low- and middle-income countries. Med Decis Making. (2018) 38: 520– 30. 10.1177/0272989X18759482 29577814 · DOI · Paper page
  5. [10]Braithwaite D Boffetta P Rebbeck TR Meyskens F. Cancer prevention for global health: a report from the Aspo International Cancer Prevention Interest Group. Cancer Epidemiol Biomarkers Prev. (2012) 21: 1606– 10. 10.1158/1055-9965.EPI-12-0848 22850804 · DOI
  6. [11]Sankaranarayanan R. Screening for cancer in low- and middle-income countries. Ann Glob Health. (2014) 80: 412– 7. 10.1016/j.aogh.2014.09.014 25512156 · DOI · Paper page
  7. [12]Cazap E Magrath I Kingham TP Elzawawy A. Structural barriers to diagnosis and treatment of cancer in low- and middle-income countries: the urgent need for scaling Up. J Clin Oncol. (2016) 34: 14– 9. 10.1200/JCO.2015.61.9189 26578618 PMC4871996 · DOI
  8. [13]Bronfenbrenner U Ceci SJ. Nature-nurture reconceptualized in developmental perspective: a bioecological model. Psychol Rev. (1994) 101: 568– 86. 10.1037/0033-295X.101.4.568 7984707 · DOI · Paper page
  9. [14]Bronfenbrenner U. Toward an experimental ecology of human development. Am Psychol. (1977) 32: 513– 31. 10.1037/0003-066X.32.7.513 · DOI · Paper page
  10. [15]Dahlgren G Whitehead M. A framework for assessing health systems from the public's perspective: the alps approach. Int J Health Serv. (2007) 37: 363– 78. 10.2190/U814-6X80-N787-807J 17665729 · DOI
  11. [16]Dahlgren G Whitehead M. The dahlgren-whitehead model of health determinants: 30 years on and still chasing rainbows. Public Health. (2021) 199: 20– 4. 10.1016/j.puhe.2021.08.009 34534885 · DOI
  12. [17]Hiatt RA Breen N. The Social determinants of cancer: a challenge for transdisciplinary science. Am J Prev Med. (2008) 35(2 Suppl): S141– 50. 10.1016/j.amepre.2008.05.006 18619394 PMC10773976 · DOI
  13. [20]Kumar S Quinn SC Kim KH Musa D Hilyard KM Freimuth VS. The social ecological model as a framework for determinants of 2009 H1n1 influenza vaccine uptake in the United States. Health Educ Behav. (2012) 39: 229– 43. 10.1177/1090198111415105 21984692 PMC3916095 · DOI
  14. [21]Warnecke RB Oh A Breen N Gehlert S Paskett E Tucker KL. Approaching health disparities from a population perspective: the national institutes of health centers for population health and health disparities. Am J public Health. (2008) 98: 1608– 15. 10.2105/AJPH.2006.102525 18633099 PMC2509592 · DOI
  15. [23]Jha P MacLennan M Chaloupka FJ Yurekli A Ramasundarahettige C Palipudi K. Global hazards of tobacco and the benefits of smoking cessation and tobacco taxes. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities. 3rd edn. Washington (DC): The International Bank for Reconstruction and Development / The World Bank. (2015). 26913345
  16. [24]Lee YC Hashibe M. Tobacco, alcohol, and cancer in low and high income countries. Ann Glob Health. (2014) 80: 378– 83. 10.1016/j.aogh.2014.09.010 25512153 · DOI
  17. [25]de Martel C Ferlay J Franceschi S Vignat J Bray F Forman D. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol. (2012) 13: 607– 15. 10.1016/S1470-2045(12)70137-7 22575588 · DOI
  18. [26]Maucort-Boulch D de Martel C Franceschi S Plummer M. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide. Int J Cancer. (2018) 142: 2471– 7. 10.1002/ijc.31280 29388206 · DOI
  19. [27]Fitzmaurice C Allen C Barber RM Barregard L Bhutta ZA Brenner H. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA oncology. (2017) 3: 524– 48. 10.1001/jamaoncol.2016.5688 27918777 PMC6103527 · DOI
  20. [28]Herrera AG. Helicobacter pylori and food products: a public health problem. Methods Mol Biol. (2004) 268: 297– 301. 10.1385/1-59259-766-1:297 15156039 · DOI
  21. [29]Zhang S Xu H Zhang L Qiao Y. Cervical cancer: epidemiology, risk factors and screening. Chin J Cancer Res. (2020) 32: 720– 8. 10.21147/j.issn.1000-9604.2020.06.05 33446995 PMC7797226 · DOI
  22. [30]Lin S Gao K Gu S You L Qian S Tang M. Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years. Cancer. (2021) 127: 4030– 9. 10.1002/cncr.33795 34368955 · DOI
  23. [31]Riley L Guthold R Cowan M Savin S Bhatti L Armstrong T. The world health organization stepwise approach to noncommunicable disease risk-factor surveillance: methods, challenges, and opportunities. Am J Public Health. (2016) 106: 74– 8. 10.2105/AJPH.2015.302962 26696288 PMC4695948 · DOI
  24. [32]Sloan FA Gelband H editors. Institute of Medicine (Us) Committee on Cancer Control in Low- and Middle-Income Countries: Cancer Control Opportunities in Low- and Middle-Income Countries. Washington (DC): National Academies Press (US). (2007). 21595106
  25. [33]Anand P Kunnumakkara AB Sundaram C Harikumar KB Tharakan ST Lai OS. Cancer is a preventable disease that requires major lifestyle changes. Pharm Res. (2008) 25: 2097– 116. 10.1007/s11095-008-9661-9 18626751 PMC2515569 · DOI · Paper page
  26. [34]Campos C Sotomayor P Jerez D Gonzalez J Schmidt CB Schmidt K. Exercise and prostate cancer: from basic science to clinical applications. Prostate. (2018) 78: 639– 45. 10.1002/pros.23502 29569731 · DOI
  27. [35]Owusu D Quinn M Wang KS Aibangbee J Mamudu HM. Intentions to quit tobacco smoking in 14 low- and middle-income countries based on the transtheoretical model. Drug Alcohol Depend. (2017) 178: 425– 9. 10.1016/j.drugalcdep.2017.05.033 28710966 · DOI
  28. [36]Zawahir S Omar M Awang R Yong HH Borland R Sirirassamee B. Effectiveness of antismoking media messages and education among adolescents in Malaysia and Thailand: findings from the international tobacco control Southeast Asia Project. Nicotine Tob Res. (2013) 15: 482– 91. 10.1093/ntr/nts161 22949569 PMC3545717 · DOI
  29. [37]Ip P Lam TH Chan SS Ho FK Lo LA Chiu IW. Use of internet viral marketing to promote smoke-free lifestyles among Chinese Adolescents. PLoS ONE. (2014) 9: e99082. 10.1371/journal.pone.0099082 24911010 PMC4049615 · DOI
  30. [38]Sankaranarayanan R. Hpv vaccination: the most pragmatic cervical cancer primary prevention strategy. Int J Gynaecol Obstet. (2015) 131 (Suppl 1): S33– 5. 10.1016/j.ijgo.2015.02.014 26433502 · DOI
  31. [39]Novaes HM de Soarez PC Silva GA Ayres A Itria A Rama CH. Cost-Effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the national immunization program in Brazil. Vaccine. (2015) 33 (Suppl 1): A135– 42. 10.1016/j.vaccine.2014.12.031 25919154 · DOI
  32. [40]Anstey EH Shoemaker ML Barrera CM O'Neil ME Verma AB Holman DM. Breastfeeding and breast cancer risk reduction: implications for black mothers. Am J Prev Med. (2017) 53: S40– s6. 10.1016/j.amepre.2017.04.024 28818244 PMC6069526 · DOI
  33. [41]Shepherd JP Frampton GK Harris P. Interventions for encouraging sexual behaviours intended to prevent cervical cancer. Cochrane Database Syst Rev. (2011) 2011: Cd001035. 10.1002/14651858.CD001035.pub2 21491379 PMC4040418 · DOI
  34. [44]Lima FE Latorre Mdo R Costa MJ Fisberg RM. Diet and cancer in Northeast Brazil: Evaluation of eating habits and food group consumption in relation to breast cancer. Cad Saude Publica. (2008) 24: 820– 8. 10.1590/S0102-311X2008000400012 18392359 · DOI
  35. [45]Sewram V Sitas F O'Connell D Myers J. Diet and esophageal cancer risk in the eastern Cape Province of South Africa. Nutr Cancer. (2014) 66: 791– 9. 10.1080/01635581.2014.916321 24877989 · DOI
  36. [46]Jordan I Hebestreit A Swai B Krawinkel MB. Dietary patterns and breast cancer risk among women in Northern Tanzania: a case-control study. Eur J Nutr. (2013) 52: 905– 15. 10.1007/s00394-012-0398-1 22729968 PMC3611024 · DOI
  37. [47]Fregnani JH Carvalho AL Eluf-Neto J Ribeiro Kde C Kuil Lde M da Silva TA. A school-based human papillomavirus vaccination program in Barretos, Brazil: final results of a demonstrative study. PLoS ONE. (2013) 8: e62647. 10.1371/journal.pone.0062647 23638130 PMC3634818 · DOI
  38. [48]Ladner J Besson MH Rodrigues M Audureau E Saba J. Performance of 21 Hpv vaccination programs implemented in low and middle-income countries, 2009-2013. BMC Public Health. (2014) 14: 670. 10.1186/1471-2458-14-670 24981818 PMC4085395 · DOI
  39. [49]Verstraeten R Roberfroid D Lachat C Leroy JL Holdsworth M Maes L. Effectiveness of preventive school-based obesity interventions in low- and middle-income countries: a systematic review. Am J Clin Nutr. (2012) 96: 415– 38. 10.3945/ajcn.112.035378 22760565 · DOI · Paper page
  40. [50]Sam KG Andrade HH Pradhan L Pradhan A Sones SJ Rao PG. Effectiveness of an educational program to promote pesticide safety among pesticide handlers of South India. Int Arch Occup Environ Health. (2008) 81: 787– 95. 10.1007/s00420-007-0263-3 17962973 · DOI
  41. [51]White JS Lowenstein C Srivirojana N Jampaklay A Dow WH. Incentive programmes for smoking cessation: cluster randomized trial in workplaces in Thailand. BMJ. (2020) 371: m3797. 10.1136/bmj.m3797 33055176 PMC7555070 · DOI
  42. [52]Levinson KL Abuelo C Chyung E Salmeron J Belinson SE Sologuren CV. The Peru cervical cancer prevention study (Percaps): community-based participatory research in Manchay, Peru. Int J Gynecol Cancer. (2013) 23: 141– 7. 10.1097/IGC.0b013e318275b007 23165314 PMC3529758 · DOI
  43. [53]Winterbauer NL Bekemeier B VanRaemdonck L Hoover AG. Applying community-based participatory research partnership principles to public health practice-based research networks. SAGE Open. (2016) 6: 10. 10.1177/2158244016679211 31131152 PMC6533003 · DOI
  44. [54]Pazoki R Nabipour I Seyednezami N Imami SR. Effects of a community-based healthy heart program on increasing healthy women's physical activity: a randomized controlled trial guided by community-based participatory research (Cbpr). BMC Public Health. (2007) 7: 216. 10.1186/1471-2458-7-216 17716376 PMC2018720 · DOI
  45. [55]Kapambwe S Parham G Mwanahamuntu M Chirwa S Mwanza J Amuyunzu-Nyamongo M. Innovative approaches to promoting cervical health and raising cervical cancer awareness by use of existing cultural structures in resource-limited countries: experiences with traditional marriage counseling in Zambia. Glob Health Promot. (2013) 20(4 Suppl): 57– 64. 10.1177/1757975913502689 24722743 · DOI
  46. [56]Chidyaonga-Maseko F Chirwa ML Muula AS. Underutilization of cervical cancer prevention services in low and middle income countries: a review of contributing factors. Pan Afr Med J. (2015) 21: 231. 10.11604/pamj.2015.21.231.6350 26523173 PMC4607967 · DOI
  47. [57]Wellensiek N Moodley M Moodley J Nkwanyana N. Knowledge of cervical cancer screening and use of cervical screening facilities among women from various socioeconomic backgrounds in Durban, Kwazulu Natal, South Africa. Int J Gynecol Cancer. (2002) 12: 376– 82. 10.1046/j.1525-1438.2002.01114.x 12144686 · DOI
  48. [59]Levy DT Ellis JA Mays D Huang AT. Smoking-related deaths averted due to three years of policy progress. Bull World Health Organ. (2013) 91: 509– 18. 10.2471/BLT.12.113878 23825878 PMC3699793 · DOI
  49. [60]Ngoan le T. Anti-smoking initiative and decline in incidence rates of lung cancer in Viet Nam. Asian Pac J Cancer Prev. (2006) 7: 492– 4. 17059354
  50. [62]Ladner J Besson MH Hampshire R Tapert L Chirenje M Saba J. Assessment of eight Hpv vaccination programs implemented in lowest income countries. BMC Public Health. (2012) 12: 370. 10.1186/1471-2458-12-370 22621342 PMC3419135 · DOI
  51. [64]Quaglia NC Dambrosio A. Helicobacter pylori: a foodborne pathogen? World J Gastroenterol. (2018) 24: 3472– 87. 10.3748/wjg.v24.i31.3472 30131654 PMC6102504 · DOI
  52. [65]Emmons KM Stoddard AM Fletcher R Gutheil C Suarez EG Lobb R. Cancer prevention among working class, multiethnic adults: results of the healthy directions-health centers study. Am J Public Health. (2005) 95: 1200– 5. 10.2105/AJPH.2004.038695 15933240 PMC1449340 · DOI
  53. [66]Loud JT Murphy J. Cancer screening and early detection in the 21(St) century. Semin Oncol Nurs. (2017) 33: 121– 8. 10.1016/j.soncn.2017.02.002 28343835 PMC5467686 · DOI
  54. [67]Ott JJ Ullrich A Miller AB. The importance of early symptom recognition in the context of early detection and cancer survival. Eur J Cancer. (2009) 45: 2743– 8. 10.1016/j.ejca.2009.08.009 19765977 · DOI
  55. [68]Adedimeji A Ajeh R Pierz A Nkeng R Ndenkeh JJ Fuhngwa N. Challenges and opportunities associated with cervical cancer screening programs in a low income, high Hiv prevalence context. BMC Women Health. (2021) 21: 74. 10.1186/s12905-021-01211-w 33602194 PMC7890622 · DOI
  56. [69]Islami F Torre LA Drope JM Ward EM Jemal A. Global cancer in women: cancer control priorities. Cancer Epidemiol Biomarkers Prev. (2017) 26: 458– 70. 10.1158/1055-9965.EPI-16-0871 28183824 · DOI
  57. [70]Sankaranarayanan R Sauvaget C Ramadas K Ngoma T Teguete I Muwonge R. Clinical trials of cancer screening in the developing world and their impact on cancer healthcare. Ann Oncol. (2011) 22 (Suppl 7): vii20- vii8. 10.1093/annonc/mdr422 22039141 · DOI
  58. [71]Kamath Mulki A Withers M. Human papilloma virus self-sampling performance in low- and middle-income countries. BMC Women Health. (2021) 21: 12. 10.1186/s12905-020-01158-4 33407355 PMC7789658 · DOI
  59. [72]Gravitt PE Belinson JL Salmeron J Shah KV. Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy. Int J Cancer. (2011) 129: 517– 27. 10.1002/ijc.25974 21384341 PMC3782104 · DOI · Paper page
  60. [73]Liebermann EJ VanDevanter N Hammer MJ Fu MR. Social and cultural barriers to women's participation in pap smear screening programs in low- and middle-income Latin American and Caribbean Countries: an integrative review. J Transcult Nurs. (2018) 29: 591– 602. 10.1177/1043659618755424 29366369 · DOI
  61. [74]WHO. Who Guidelines Approved by the Guidelines Review Committee. Who Position Paper on Mammography Screening. Geneva: World Health Organization. (2014). 25642524
  62. [75]Lauby-Secretan B Scoccianti C Loomis D Benbrahim-Tallaa L Bouvard V Bianchini F. Breast-cancer screening–viewpoint of the iarc working group. N Engl J Med. (2015) 372: 2353– 8. 10.1056/NEJMsr1504363 26039523 · DOI
  63. [76]Dey S. Preventing breast cancer in lmics via screening and/or early detection: the real and the surreal. World J Clin Oncol. (2014) 5: 509– 19. 10.5306/wjco.v5.i3.509 25114864 PMC4127620 · DOI
  64. [77]Omidiji OA Campbell PC Irurhe NK Atalabi OM Toyobo OO. Breast cancer screening in a resource poor country: ultrasound versus mammography. Ghana Med J. (2017) 51: 6– 12. 10.4314/gmj.v51i1.2 28959066 PMC5611948 · DOI
  65. [78]Fauziah Abdullah MOR Liam Murray Tin Tin Su. Evaluation of a worksite cervical screening initiative to increase pap smear uptake in Malaysia: a cluster randomized controlled trial. Biomed Res Int. (2013) 2013: 572126. 10.1155/2013/572126 24073411 PMC3773923 · DOI
  66. [79]Ma GX Yin L Gao W Tan Y Liu R Fang C. Workplace-based breast cancer screening intervention in China. Cancer Epidemiol Biomarkers Prev. (2012) 21: 358– 67. 10.1158/1055-9965.EPI-11-0915 22155948 · DOI
  67. [80]Schrammel P Griffiths RI Griffiths CB. A workplace breast cancer screening program. Costs and Components. AAOHN J. (1998) 46: 523– 9. 10.1177/216507999804601102 9934000 · DOI
  68. [81]Nahmias Z Townsend JS Neri A Stewart SL. Worksite cancer prevention activities in the national comprehensive cancer control program. J Community Health. (2016) 41: 838– 44. 10.1007/s10900-016-0161-2 26874944 PMC4930403 · DOI
  69. [82]Sankaranarayanan R. 'See-and-Treat' works for cervical cancer prevention: what about controlling the high burden in India? Indian J Med Res. (2012) 135: 576– 9. 22771586 PMC3401687
  70. [83]Nuranna L Aziz MF Cornain S Purwoto G Purbadi S Budiningsih S. Cervical cancer prevention program in Jakarta, Indonesia: see and treat model in developing country. J Gynecol Oncol. (2012) 23: 147– 52. 10.3802/jgo.2012.23.3.147 22808356 PMC3395009 · DOI
  71. [84]Huchko MJ Ibrahim S Blat C Cohen CR Smith JS Hiatt RA. Cervical cancer screening through human papillomavirus testing in community health campaigns versus health facilities in rural western Kenya. Int J Gynaecol Obstet. (2018) 141: 63– 9. 10.1002/ijgo.12415 29197067 PMC7369666 · DOI
  72. [85]Shen J Olwanda E Kahn JG Huchko MJ. Cost of Hpv Screening at Community Health Campaigns (Chcs) and Health Clinics in Rural Kenya. BMC Health Serv Res. (2018) 18: 378. 10.1186/s12913-018-3195-6 29801496 PMC5970469 · DOI
  73. [86]Mauad EC Nicolau SM Gomes UA da Costa Vieira RA de Castro Mattos JS Longatto-Filho A. Can mobile units improve the strategies for cervical cancer prevention? Diagn Cytopathol. (2010) 38: 727– 30. 10.1002/dc.21287 20014304 · DOI
  74. [87]Mauad EC Nicolau SM Moreira LF Haikel RL Jr Longatto-Filho A Baracat EC. Adherence to cervical and breast cancer programs is crucial to improving screening performance. Rural Remote health. (2009) 9: 1241. 10.22605/RRH1241 19778158 · DOI
  75. [88]Stefan DC Elzawawy AM Khaled HM Ntaganda F Asiimwe A Addai BW. Developing cancer control plans in Africa: examples from five countries. Lancet Oncol. (2013) 14: e189– 95. 10.1016/S1470-2045(13)70100-1 23561751 · DOI
  76. [89]WHO. National Cancer Control Programs Policies and Managerial Guidelines. (2002). Available online at: https://apps.who.int/iris/handle/10665/42494 12587230
  77. [90]Holme F Kapambwe S Nessa A Basu P Murillo R Jeronimo J. Scaling up proven innovative cervical cancer screening strategies: challenges and opportunities in implementation at the population level in low- and lower-middle-income countries. Int J Gynaecol Obstet. (2017) 138 (Suppl 1): 63– 8. 10.1002/ijgo.12185 28691331 · DOI
  78. [91]Hussain SA Sullivan R. Cancer control in Bangladesh. Jpn J Clin Oncol. (2013) 43: 1159– 69. 10.1093/jjco/hyt140 24163419 PMC3842101 · DOI
  79. [92]Chary AN Rohloff PJ. Major challenges to scale up of visual inspection-based cervical cancer prevention programs: the experience of guatemalan ngos. Glob Health Sci Pract. (2014) 2: 307– 17. 10.9745/GHSP-D-14-00073 25276590 PMC4168631 · DOI
  80. [93]Vijayvergia N Denlinger CS. Lifestyle factors in cancer survivorship: where we are and where we are headed. J Pers Med. (2015) 5: 243– 63. 10.3390/jpm5030243 26147495 PMC4600146 · DOI
  81. [94]Ligibel J. Lifestyle factors in cancer survivorship. J Clin Oncol. (2012) 30: 3697– 704. 10.1200/JCO.2012.42.0638 23008316 · DOI
  82. [95]Schoenberg MH. Physical activity and nutrition in primary and tertiary prevention of colorectal cancer. Visceral medicine. (2016) 32: 199– 204. 10.1159/000446492 27493948 PMC4945783 · DOI
  83. [96]McCutchan G Weiss B Quinn-Scoggins H Dao A Downs T Deng Y. Psychosocial influences on help-seeking behaviour for cancer in low-income and lower middle-income countries: a mixed-methods systematic review. BMJ Glob Health. (2021) 6: e004213. 10.1136/bmjgh-2020-004213 33531348 PMC7868297 · DOI
  84. [97]Demark-Wahnefried W Rogers LQ Alfano CM Thomson CA Courneya KS Meyerhardt JA. Practical clinical interventions for diet, physical activity, and weight control in cancer survivors. CA Cancer J Clin. (2015) 65: 167– 89. 10.3322/caac.21265 25683894 · DOI · Paper page
  85. [98]Veenstra CM Abrahamse P Wagner TH Hawley ST Banerjee M Morris AM. Employment benefits and job retention: evidence among patients with colorectal cancer. Cancer Med. (2018) 7: 736– 45. 10.1002/cam4.1371 29473344 PMC5852372 · DOI
  86. [99]Heymann J Raub A Waisath W McCormack M Weistroffer R Moreno G. Protecting health during Covid-19 and beyond: a global examination of paid sick leave design in 193 countries. Glob Public Health. (2020) 15: 925– 34. 10.1080/17441692.2020.1764076 32396447 · DOI
  87. [100]Hannon B Zimmermann C Knaul FM Powell RA Mwangi-Powell FN Rodin G. Provision of palliative care in low- and middle-income countries: overcoming obstacles for effective treatment delivery. J Clin Oncol. (2016) 34: 62– 8. 10.1200/JCO.2015.62.1615 26578612 · DOI
  88. [101]Finocchario-Kessler S Wexler C Maloba M Mabachi N Ndikum-Moffor F Bukusi E. Cervical cancer prevention and treatment research in Africa: a systematic review from a public health perspective. BMC Women Health. (2016) 16: 29. 10.1186/s12905-016-0306-6 27259656 PMC4893293 · DOI
  89. [102]Salminen E Izewska J Andreo P. Iaea's role in the global management of cancer-focus on upgrading radiotherapy services. Acta Oncol. (2005) 44: 816– 24. 10.1080/02841860500341355 16332588 · DOI
  90. [103]Harding R Higginson IJ. Palliative care in sub-saharan Africa. Lancet. (2005) 365: 1971– 7. 10.1016/S0140-6736(05)66666-4 15936427 · DOI
  91. [104]Yoo KY. Cancer prevention in the Asia Pacific region. Asian Pac J Cancer Prev. (2010) 11: 839– 44. 21133587

Authors
Akinyemiju, T., Ogunsina, K., Gupta, A., Liu, I., Braithwaite, D., & Hiatt, R. A.
Affiliations
  • Duke University (US)
  • University of Florida Health (US)
  • University of California, San Francisco (US)
Corresponding author
Akinyemiju, Tomi
ORCID
Venue
Frontiers in Public Health
Publisher
Frontiers Media SA
Published
2022-05-26
Volume
10
Pages
884678-884678
ISSN
2296-2565 (ISSN-L)
DOI
10.3389/fpubh.2022.884678
PMC
PMC9204349
OpenAlex
W4281611784
Cited by
48
References
92
Citations by year
2026: 12 · 2025: 20 · 2024: 7 · 2023: 9
FWCI
1.10
Type
journal article
Language
en
Open access
Licence
Locations
  • Frontiers in Public Health (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
National Institute on Aging (P30AG028740)
Topics
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advances in Oncology and Radiotherapy
  • Social Sciences › Business, Management and Accounting › Organizational Behavior and Human Resource Management › Global Public Health Policies and Epidemiology
Keywords
cancer prevention, socio-ecological framework, low- and middle-income countries, cancer control programs, primary prevention, secondary prevention, tertiary prevention, cancer screening, cancer survivorship, access to cancer care, tobacco use, alcohol consumption, diet and cancer risk, cancer vaccines, health policy, non-communicable disease prevention, community participation
MeSH terms
Delivery of Health Care, Developing Countries, Humans, Income, Neoplasms, Poverty

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review